Related by context. Frequent words. (Click for all words.) 68 SABCS 67 Clinical Trial Results 65 Acute Myocardial Infarction 65 Percutaneous Coronary Intervention 63 Postmenopausal Women 63 Preclinical Data 62 Transcatheter Cardiovascular Therapeutics TCT 62 Heart Failure Patients 62 Solid Tumors 62 Completes Enrollment 62 AACR NCI EORTC 61 Phase III Clinical Trial 61 Overactive Bladder 61 Oral Presentation 61 Pivotal Trial 61 Meta Analysis 61 Pulmonary Arterial Hypertension 61 Metastatic Melanoma 61 Elderly Patients 60 Anticoagulation 60 Acute Coronary Syndrome 60 Transcatheter Cardiovascular Therapeutics 60 Drug Eluting Stents 60 Monotherapy 59 CROI 59 Chronic Hepatitis C 59 Phase III Trial 59 SPIRIT IV 59 EuroPCR 59 Pivotal Phase 59 Pivotal Phase III 59 ASCO Annual Meeting 58 Poster Session 58 Poster Presentation 58 annual Transcatheter Cardiovascular 58 Presents Positive 58 Scientific Session 58 AASLD 58 Annual Scientific Sessions 57 Clinical Oncology Annual Meeting 57 LymphoStat B 57 Drug Candidate 57 J Am Coll 57 Hematology Annual Meeting 57 Bladder Cancer 56 Pirfenidone 56 Opportunistic Infections CROI 56 Low Dose 56 Targeted Therapy 56 Digestive Disease Week 56 Phase Ib clinical 56 Digestive Disease Week DDW 56 KRN# 56 Patient Recruitment 56 ICAAC 56 Upcoming Conferences 56 Vascular Disease 56 Traficet EN 56 Ischemic 55 Multicenter 55 SPIRIT III 55 Epratuzumab 55 Cardiovascular Risk 55 Thrombolysis 55 Catheterization 55 Chronic Lymphocytic Leukemia 55 pertuzumab 55 Breast Cancer Symposium 55 ACCLAIM 55 CTI Nasdaq 55 EASL 55 BIO InvestorForum 55 Abstract Number 55 Arch Neurol 55 Pharmacokinetic 55 Benign Prostatic Hyperplasia 54 EORTC NCI AACR 54 Phase 1b 54 ENDO 54 J Natl Cancer Inst 54 Cardiology ACC 54 ARVO 54 Arch Intern Med 54 Cardiology ESC 54 placebo controlled clinical 54 tanespimycin 54 Phase 1b trial 54 Enoxaparin 53 phase IIb clinical 53 DDP# 53 Rivaroxaban 53 J Am Acad 53 Arteriosclerosis Thrombosis 53 Heart Failure 53 Oncologic Drugs Advisory 53 Hematology ASH Annual Meeting 53 RADIANT 53 J Clin Oncol 53 Carfilzomib 53 Natalizumab 53 substudy